Latest Market Prices News

Lynas Rare Earths Ltd has reported a striking half-year turnaround with a 1260% surge in net profit, underpinned by rising rare earth prices and strategic expansions. The company also completed a major equity raise to fuel its ambitious Towards 2030 growth plan.

Suncorp Group Limited has updated its dividend distribution details, confirming a fully franked ordinary dividend of AUD 0.17 per share payable in March 2026, with tailored currency payment options for shareholders.

TPC Consolidated Limited reported a 4.1% revenue increase to $103.6 million and a 62% jump in underlying EBITDA for the half-year ended December 2025, while the proposed acquisition scheme faces regulatory hurdles.

Generation Development Group’s half-year results reveal a sharp 91% drop in net profit despite a 21% revenue decline, yet the company maintains its interim dividend at 1 cent per share.

Academies Australasia Group reported a 21% reduction in net loss for the half year to December 2025, alongside a strategic share buy-back and increased director lending. Despite a 6% revenue dip, EBITDA remained steady, signalling cautious operational resilience.

Lendlease Group reported a significant $318 million statutory loss for the half year ended December 2025, driven by impairments and lower transaction earnings. The company plans a $3 billion capital recycling program to reduce gearing and strengthen its balance sheet.

Stanmore Resources delivered record coal production and strong cash flow in 2025 despite softer market prices, declaring a fully franked dividend and guiding a modest production decline for 2026.

Ampol Limited’s 2025 results reveal a sharp drop in statutory profit amid lower revenue, yet a robust rise in replacement cost operating profit signals resilience beneath the surface.

Cadence Capital Limited has reported a remarkable turnaround with a 508% surge in profit after tax for the half-year ended December 2025, alongside a fully franked interim dividend declaration.

WAM Strategic Value Limited has reported a robust half-year performance, with net profit soaring 158.6% and an increased fully franked interim dividend. The company’s investment portfolio outperformed the market, underpinning strong shareholder returns.

AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.

BKI Investment Company has finalised its on-market share purchases to satisfy its Dividend Reinvestment Plan obligations, setting the DRP price at $1.74 ahead of the 2026 interim dividend payment.